151 related articles for article (PubMed ID: 25422244)
1. Retrospective evaluation of discrepancies between radiological and pathological size of hepatocellular carcinoma masses.
Tian F; Wu JX; Rong WQ; Wang LM; Wu F; Yu WB; An SL; Liu FQ; Feng L; Liu YH
Asian Pac J Cancer Prev; 2014; 15(21):9487-94. PubMed ID: 25422244
[TBL] [Abstract][Full Text] [Related]
2. Role of FDG-PET in the evaluation and staging of hepatocellular carcinoma with comparison of tumor size, AFP level, and histologic grade.
Wolfort RM; Papillion PW; Turnage RH; Lillien DL; Ramaswamy MR; Zibari GB
Int Surg; 2010; 95(1):67-75. PubMed ID: 20480845
[TBL] [Abstract][Full Text] [Related]
3. Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators.
Bhattacharjya S; Bhattacharjya T; Quaglia A; Dhillon AP; Burroughs AK; Patch DW; Tibballs JM; Watkinson AF; Rolles K; Davidson BR
Dig Surg; 2004; 21(2):152-9; discussion 159-60. PubMed ID: 15166485
[TBL] [Abstract][Full Text] [Related]
4. [Discrepancy between radiological and pathological sizes of renal masses].
Huang JW; Dong BJ; Zhang J; Kong W; Xue W; Liu DM; Huang YR
Zhonghua Zhong Liu Za Zhi; 2013 Jun; 35(6):429-33. PubMed ID: 24119902
[TBL] [Abstract][Full Text] [Related]
5. Assessment of preoperative magnetic resonance imaging staging in patients with hepatocellular carcinoma undergoing resection compared with the seventh American Joint Committee on Cancer System.
An C; Choi GH; Lee HS; Kim MJ
Invest Radiol; 2012 Nov; 47(11):634-41. PubMed ID: 22814590
[TBL] [Abstract][Full Text] [Related]
6. Ferumoxide-enhanced MR imaging of hepatocellular carcinoma: correlation with histologic tumor grade and tumor vascularity.
Kato H; Kanematsu M; Kondo H; Goshima S; Matsuo M; Hoshi H; Moriyama N
J Magn Reson Imaging; 2004 Jan; 19(1):76-81. PubMed ID: 14696223
[TBL] [Abstract][Full Text] [Related]
7. [Staging of hepatocellular carcinoma. Comparison of ultrasonography, computerized tomography, magnetic resonance, digital angiography, and computerized tomography with lipiodol].
Bartolozzi C; Lencioni R; Caramella D; Gibilisco G; Cioni R; Vignali C
Radiol Med; 1994 Oct; 88(4):429-36. PubMed ID: 7997616
[TBL] [Abstract][Full Text] [Related]
8. Retrospective clinicopathologic correlation of gross tumor size of hepatocellular carcinoma: implications for stereotactic body radiotherapy.
Kelsey CR; Schefter T; Nash SR; Russ P; BarĂ³n AE; Zeng C; Gaspar LE
Am J Clin Oncol; 2005 Dec; 28(6):576-80. PubMed ID: 16317267
[TBL] [Abstract][Full Text] [Related]
9. Gd-EOB-DTPA-enhanced MRI is better than MDCT in decision making of curative treatment for hepatocellular carcinoma.
Yoo SH; Choi JY; Jang JW; Bae SH; Yoon SK; Kim DG; Yoo YK; Rha SE; Lee YJ; Jung ES
Ann Surg Oncol; 2013 Sep; 20(9):2893-900. PubMed ID: 23649931
[TBL] [Abstract][Full Text] [Related]
10. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
[TBL] [Abstract][Full Text] [Related]
11. MRI of Small Hepatocellular Carcinoma: Typical Features Are Less Frequent Below a Size Cutoff of 1.5 cm.
Choi MH; Choi JI; Lee YJ; Park MY; Rha SE; Lall C
AJR Am J Roentgenol; 2017 Mar; 208(3):544-551. PubMed ID: 28026208
[TBL] [Abstract][Full Text] [Related]
12. Laparoscopic staging and tumor ablation for hepatocellular carcinoma in Child C cirrhotics evaluated for orthotopic liver transplantation.
Kim RD; Nazarey P; Katz E; Chari RS
Surg Endosc; 2004 Jan; 18(1):39-44. PubMed ID: 14625751
[TBL] [Abstract][Full Text] [Related]
13. Clinical effect of add-on Primovist-enhanced magnetic resonance imaging on preoperative tumor staging in hepatocellular carcinoma patients.
Jin YJ; Lee JW; Kwon OS; Jung YK; Kwon JH; Jang JW; Kim YS; Kim TH; Jeon YS
J Surg Oncol; 2016 Jul; 114(1):106-11. PubMed ID: 27332047
[TBL] [Abstract][Full Text] [Related]
14. T1 mapping combined with Gd-EOB-DTPA-enhanced magnetic resonance imaging in predicting the pathologic grading of hepatocellular carcinoma.
Chen CY; Chen J; Xia CC; Huang ZX; Song B
J Biol Regul Homeost Agents; 2017; 31(4):1029-1036. PubMed ID: 29254310
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic value of multislice spiral CT and MRI in detection of tumor recurrence after liver transplantation for hepatocellular carcinoma].
Wang J; He BJ; Jiang ZB; Zhang YQ; Shan H; Xiao R; Zhang JS; Luo L; Kuang SC; Chen GH; Yang Y
Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):691-6. PubMed ID: 20021867
[TBL] [Abstract][Full Text] [Related]
16. Correlations between the minimum and mean apparent diffusion coefficient values of hepatocellular carcinoma and tumor grade.
Li X; Zhang K; Shi Y; Wang F; Meng X
J Magn Reson Imaging; 2016 Dec; 44(6):1442-1447. PubMed ID: 27228086
[TBL] [Abstract][Full Text] [Related]
17. Subtraction Images of Gadoxetic Acid-Enhanced MRI: Effect on the Diagnostic Performance for Focal Hepatic Lesions in Patients at Risk for Hepatocellular Carcinoma.
Choi SH; Kim SY; Lee SS; Shim JH; Byun JH; Baek S; Lee MG
AJR Am J Roentgenol; 2017 Sep; 209(3):584-591. PubMed ID: 28609188
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular Carcinoma: Retrospective Evaluation of the Correlation Between Gadobenate Dimeglumine-Enhanced Magnetic Resonance Imaging and Pathologic Grade.
Huang X; Xiao Z; Zhang Y; Lin N; Xiong M; Huang X; Chen Q; Cao D
J Comput Assist Tomogr; 2018; 42(3):365-372. PubMed ID: 29369947
[TBL] [Abstract][Full Text] [Related]
19. Role of MRI with hepatospecific contrast agent in the identification and characterization of focal liver lesions: pathological correlation in explanted livers.
Orlacchio A; Chegai F; Fabiano S; Merolla S; Funel V; Di Giuliano F; Manuelli M; Tisone G; Francioso S; Angelico M; Palmieri G; Simonetti G
Radiol Med; 2016 Jul; 121(7):588-96. PubMed ID: 27100719
[TBL] [Abstract][Full Text] [Related]
20. Validated preoperative computed tomography risk estimation for postoperative hepatocellular carcinoma recurrence.
Zhang W; Lai SL; Chen J; Xie D; Wu FX; Jin GQ; Su DK
World J Gastroenterol; 2017 Sep; 23(35):6467-6473. PubMed ID: 29085196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]